Information Library

Managed Partnerships

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by:
  • Most Recent
  • Title

  • PHARMAXIS SELECTS QUINTILES TO COMMERCIALIZE BRONCHITOL

    August 31, 2010 – Quintiles announced a strategic agreement with Pharmaxis to provide a broad range of commercial solutions to support the European launch of Bronchitol®, an innovative treatment for cystic fibrosis.

  • Capital - sharing risks, expanding opportunities

    July 14, 2010
    This Capital brochure reviews how Quintiles helps biopharma allies maximize the value of assets, reduce risk, accelerate outcomes and increase rewards.

  • Targeting Oncology

    June 2, 2010
    Learn more about Quintiles leadership in oncology product development and commercialization.

  • Eric Siemers, MD

    May 20, 2010
    Eric Siemers, MD Medical Director, Alzheimer’s Disease Eli Lilly Eric Siemers, M.D. is Medical Director of the Alzheimer’s Disease Team at Eli Lilly

  • Focused Co-Promotion

    May 9, 2010
    Roche Italy needed to find new, cost-effective ways to underpin sales of mature products. Uncover what happened when a unique partnership with Quintiles reinforced sales growth.

  • Mapping the Future in Oncology Drug Development

    June 5, 2010
    Improving the development of oncology drugs is a high priority in order to enhance patient outcomes.

  • PharmAsia News Article Reprint

    March 1, 2010
    Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News.

  • Managing Alliances with the Balanced Scorecard

    January 11, 2010
    “Managing Alliances with the Balanced Scorecard” details how Solvay Pharmaceuticals and Quintiles managed their innovative development alliance to deliver value for both companies.

  • Managing Alliances with the Balanced Scorecard

    January 11, 2010
    Robert S. Kaplan, Baker Foundation Professor at Harvard Business School, explains why corporate alliances often fail, and how Solvay Pharmaceuticals and Quintiles achieved success through

  • Managing Alliances with the Balanced Scorecard

    January 11, 2010
    One particularly well done aspect of the Solvay-Quintiles alliance was its use of multiple committees and teams to keep the alliance on track and deliver

Page 1 of 5 (42 results)

Subscribe to Email Based on Your Interests

Set preferences